These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2234099)

  • 1. Pharmacokinetic properties of the antimuscarinic drug [3H]-hexahydro-sila-difenidol in the rat.
    Rettenmayr NM; Rodrigues de Miranda JF; Rijntjes NV; Russel FG; van Ginneken CA; Strohmann C; Tacke R; Lambrecht G; Mutschler E
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Aug; 342(2):146-52. PubMed ID: 2234099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding and functional properties of antimuscarinics of the hexocyclium/sila-hexocyclium and hexahydro-diphenidol/hexahydro-sila-diphenidol type to muscarinic receptor subtypes.
    Waelbroeck M; Tastenoy M; Camus J; Christophe J; Strohmann C; Linoh H; Zilch H; Tacke R; Mutschler E; Lambrecht G
    Br J Pharmacol; 1989 Sep; 98(1):197-205. PubMed ID: 2804545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled compound.
    Sugihara K; Morino A; Nomura A; Iida S; Sugiyama M
    Arzneimittelforschung; 1990 Jul; 40(7):800-5. PubMed ID: 2222556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
    Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
    Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats.
    Duchêne P; Giudicelli MD; Neau B; Gronfier A; Firmin Y; Villax P; Saivin S; Houin G
    Arzneimittelforschung; 1998 Apr; 48(4):371-8. PubMed ID: 9608879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology of hexahydro-difenidol, hexahydro-sila-difenidol and related selective muscarinic antagonists.
    Lambrecht G; Feifel R; Moser U; Wagner-Röder M; Choo LK; Camus J; Tastenoy M; Waelbroeck M; Strohmann C; Tacke R
    Trends Pharmacol Sci; 1989 Dec; Suppl():60-4. PubMed ID: 2694525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and metabolism of the antiarrhythmic agent [3H]-diprafenone in the rat.
    Brunner F; Kolmayr U; Kukovetz WR
    Arzneimittelforschung; 1989 Nov; 39(11):1430-5. PubMed ID: 2619776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Metabolic fate of bufalin in rats].
    Toma S; Hirai Y; Sugimoto C; Shoji M; Oguni Y; Morishita S; Ito C; Horie M
    Yakugaku Zasshi; 1991 Nov; 111(11):676-86. PubMed ID: 1783982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism and excretion of 14C-tiropramide after single intravenous or peroral administration to the rat.
    Setnikar I; Makovec F; Chistè R; Giachetti C; Zanolo G
    Arzneimittelforschung; 1989 Mar; 39(3):328-34. PubMed ID: 2757659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.
    Mukai H; Sugimoto T; Ago M; Morino A
    Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
    Okuyama Y; Momota K; Morino A
    Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition and metabolism of [14C]-haloperidol in rats.
    Miyazaki H; Matsunaga Y; Nambu K; Oh-e Y; Yoshida K; Hashimoto M
    Arzneimittelforschung; 1986 Mar; 36(3):443-52. PubMed ID: 3707663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Absorption, distribution, excretion and metabolism of [14C] T-3761 in rats and mice].
    Hayakawa H; Hayashi K; Sakai H; Ishikura H; Takagi H; Nakajima Y; Sogame Y
    Jpn J Antibiot; 1995 May; 48(5):671-85. PubMed ID: 7637202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of tiropramide and metabolites after single intravenous or peroral administration of 14C-tiropramide to the rat.
    Setnikar I; Makovec F; Chistè R; Giachetti C; Zanolo G
    Arzneimittelforschung; 1989 May; 39(5):579-86. PubMed ID: 2757674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition of the opioid antagonist, LY255582, in rats and dogs.
    Swanson SP; Catlow J; Pohland RC; Chay SH; Johnson T
    Drug Metab Dispos; 1995 Sep; 23(9):916-21. PubMed ID: 8565781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on absorption, distribution and excretion of 14C labeled (+-)-7-(3-amino-1-pyrrolidinyl)-6-fluoro-1-(2,4-difluorophenyl)-1,4- dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid p-toluene-sulfonate hydrate (14C-T-3262) in rats and mice].
    Maeda T; Sakai H; Hayakawa H; Hayashi K; Yoneda K
    Jpn J Antibiot; 1989 Apr; 42(4):854-67. PubMed ID: 2769938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution and excretion of methamphetamine and its metabolites in rats. III. Time-course of concentrations in blood and bile, and distribution after intravenous administration.
    Sakai T; Niwaguchi T; Kimura R; Murata T
    Xenobiotica; 1985 Jan; 15(1):31-40. PubMed ID: 3984382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding affinities of hexahydro-difenidol and hexahydro-sila-difenidol analogues at four muscarinic receptor subtypes: constitutional and stereochemical aspects.
    Waelbroeck M; Camus J; Tastenoy M; Mutschler E; Strohmann C; Tacke R; Lambrecht G; Christophe J
    Eur J Pharmacol; 1991 Feb; 206(2):95-103. PubMed ID: 2065719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.